Lower levels of 25-hydroxyvitamin D3 are associated with a higher prevalence of microvascular complications in patients with type 2 diabetes

BMJ Open Diabetes Research and Care

Volumn 3, Issue 1, 2015, Pages

  Zoppini, Giacomo ^a   Galletti, Anna ^a   Targher, Giovanni ^a   Brangani, Corinna ^a   Pichiri, Isabella ^a   Trombetta, Maddalena ^a   Negri, Carlo ^a   de Santi, Francesca ^a   Stoico, Vincenzo ^a   Cacciatori, Vittorio ^a   Bonora, Enzo ^a  

^a UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIFEDIOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PARATHYROID HORMONE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CHEMILUMINESCENCE IMMUNOASSAY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; EYE EXAMINATION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; URINALYSIS; VERY ELDERLY; VITAMIN D DEFICIENCY;

EID: 85011921551     PISSN: None     EISSN: 20524897     Source Type: Journal    
DOI: 10.1136/bmjdrc-2014-000058     Document Type: Article

References (40)

1. Koshiyama H, Ikeda H, Honjo S, et al. Hypovitaminosis D is frequent in Japanese subjects with type 2 diabetes. Diabetes Res Clin Pract 2007;76:470-1.
2. Isaia G, Giorgino R, Adami S. High prevalence of hypovitaminosis D in female type 2 diabetic population. Diabetes Care 2001;24:1496-500.
3. Joergensen C, Gall MA, Schmedes A, et al. Vitamin D levels and mortality in type 2 diabetes. Diabetes Care 2010;33:2238-43.
4. Zheng Y, Zhu J, Zhou M, et al. Meta-analysis of long-term vitamin D supplementation on overall mortality. PLoS ONE 2013;8:e82109.
5. Soedamah-Muthu SS, Chaturvedi N, Witte DR, et al. EURODIAB Prospective Complications Study Group. Relationship between risk factors and mortality in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study (PCS). Diabetes Care 2008;31:1360-6.
6. Targher G, Zoppini G, Chonchol M, et al. Glomerular filtration rate, albuminuria and risk of cardiovascular and all-cause mortality in type 2 diabetic individuals. Nutr Metab Cardiovasc Dis 2011;21:294-301.
7. Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev 2013;93:137-88.
8. Patrick PA, Visintainer PF, Shi Q, et al. Vitamin D and retinopathy in adults with diabetes mellitus. Arch Ophthalmol 2012;130:756-60.
9. Aksoy H, Akçay F, Kurtul N, et al. Serum 1, 25 dihydroxy-vitamin D (1, 25(OH)2D3), 25 hydroxy-vitamin D (25(OH)D) and parathormone levels in diabetic retinopathy. Clin Biochem 2000;33:47-51.
10. Diaz VA, Mainous AG, Carek PJ, et al. The association of vitamin D deficiency and insufficiency with diabetic nephropathy: implications for health disparities. J Am Board Fam Med 2009;22:521-7.
11. Joergensen C, Hovind P, Schmedes A, et al. Vitamin D levels, microvascular complications, and mortality in type 1 diabetes. Diabetes Care 2011;34:1081-5.
12. Suzuki A, Kotake M, Ono Y, et al. Hypovitaminosis D in type 2 diabetes mellitus: association with microvascular complications and type of treatment. Endocr J 2006;53:503-10.
13. Stevens LA, Coresh J, Greene T, et al. Assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med 2010;354:2473-83.
14. Cigolini M, Iagulli MP, Miconi V, et al. Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients. Diabetes Care 2006;29:722-4.
15. Hossein-Nezhad A, Holick MF. Vitamin D for health: a global perspective. Mayo Clin Proc 2013;88:720-55.
16. Targher G, Pichiri I, Lippi G. Vitamin D, thrombosis, and hemostasis: more than skip deep. Semin Thromb Hemost 2012;38:114-24.
17. Ginde AA, Liu MC, Camargo CA. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med 2009;169:626-32.
18. Lippi G, Montagnana M, Meschi T, et al. Vitamin D concentration and deficiency across different ages and genders. Aging Clin Exp Res 2012;24:548-51.
19. Cigolini M, Miconi V, Soffiati G, et al. Hypovitaminosis D among unselected medical inpatients and outpatients in Northern Italy. Clin Endocrinol (Oxf) 2006;64:475.
20. Payne JF, Ray R, Watson DG, et al. Vitamin D insufficiency in diabetic retinopathy. Endocr Pract 2012;18:185-93.
21. Soderstrom LH, Johnson SP, Diaz VA, et al. Association between vitamin D and diabetic neuropathy in a nationally representative sample: results from 2001-2004 NHANES. Diabet Med 2012;29:50-5.
22. Shehab D, Al-Jarallah K, Mojiminiyi OA, et al. Does vitamin D deficiency play a role in peripheral neuropathy in type 2 diabetes? Diabet Med 2012;29:43-9.
23. Fernández-Juárez G, Luño J, Barrio V, et al. PRONEDI Study Group. 25(OH)-vitamin D levels and renal disease progression in patients with type 2 diabetic nephropathy and blockade of the renin-angiotensin system. Clin J Am Soc Nephrol 2013;8:1870-6.
24. Ahmadi N, Mortazavi M, Iraj B, et al. Whether vitamin D3 is effective in reducing proteinuria in type 2 diabetic patients? J Res Med Sci 2013;18:374-7.
25. Kaur H, Donaghue KC, Chan AK, et al. Vitamin D deficiency is associated with retinopathy in children and adolescents with type 1 diabetes. Diabetes Care 2011;34:1400-2.
26. Mantell DJ, Owens PE, Bundred NJ, et al. 1α, 25-Dihydroxyvitamin D3 inhibits angiogenesis in vitro and in vivo. Circ Res 2000;87:214-20.
27. Albert DM, Scheef EA, Wang S, et al. Calcitriol is a potent inhibitor of retinal neovascularization. Invest Ophthalmol Vis Sci 2007;48:2327-34.
28. Majewski S, Skopinska M, Marczak M, et al. Vitamin D3 is a potent inhibitor of tumour cell-induced angiogenesis. J Investig Dermatol Symp Proc 1996;1:97-101.
29. Taverna MJ, Selam JL, Slama G. Association between a protein polymorphism in the start codon of the vitamin D receptor gene and severe diabetic retinopathy in C-peptide-negative type 1 diabetes. J Clin Endocrinol Metab 2005;90:4803-8.
30. Amer M, Qayyum R. Relation between serum 25-hydroxyvitamin D and C-reactive protein in asymptomatic adults (from the continuous National Health and Nutrition Examination Survey 2001 to 2006). Am J Cardiol 2012;109:226-30.
31. Jorde R, Strand Hutchinson M, Kjaergaard M, et al. Supplementation with high doses of vitamin D to subjects without vitamin D deficiency may have negative effects: pooled data from four intervention trials in Tromso. ISRN Endocrinol 2013;2013:348705.
32. Gepner AD, Ramamurthy R, Krueger DC, et al. A prospective randomized controlled trial of the effects of vitamin D supplementation on cardiovascular disease risk. PLoS ONE 2012;7:e36617.
33. Zhang Z, Sun L, Wang Y, et al. Reno-protective role of the vitamin D receptor in diabetic nephropathy. Kidney Int 2008;73:163-71.
34. Zhang Z, Yuan W, Sun L, et al. 1, 25-Dihydroxyvitamin D3 targeting of NF-κB suppresses high glucose-induced MCP-1 expression in mesangial cells. Kidney Int 2007;72:193-201.
35. Plum LA, Zella JB. Vitamin D compounds and diabetic nephropathy. Arch Biochem Biophys 2012;523:87-94.
36. Kim MJ, Frankel AH, Donaldson M, et al. Oral cholecalciferol decreases albuminuria and urinary TGF-β1 in patients with type 2 diabetic nephropathy on established renin-angiotensin-aldosterone system inhibition. Kidney Int 2011;80:851-60.
37. Liu Z, Liu L, Chen X, et al. Associations study of vitamin D receptor gene polymorphisms with diabetic microvascular complications: a meta-analysis. Gene 2014;546:6-10.
38. Chowdhury R, Kunutsor S, Vitezova A, et al. Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ 2014;348:g1903.
39. Autier P, Boniol M, Pizot C, et al. Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol 2014;2:76-89.
40. Bolland MJ, Grey A, Gamble GD, et al. Vitamin D supplementation and falls: a trial sequential meta-analysis. Lancet Diabetes Endocrinol 2014;2:573-80.